Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAPK3 | O43293 | 1/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | RET | P07949 | 1/20 | 0.35 |
| ▸ | MET | P08581 | 1/20 | 0.35 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.35 |
| ▸ | PRKACA | P17612 | 1/20 | 0.35 |
| ▸ | LTK | P29376 | 1/20 | 0.35 |
| ▸ | GRK5 | P34947 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.35 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.35 |
| ▸ | CDK8 | P49336 | 1/20 | 0.35 |
| ▸ | CLK2 | P49760 | 1/20 | 0.35 |
| ▸ | CDK7 | P50613 | 1/20 | 0.35 |
| ▸ | CDK9 | P50750 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526829 | 0.81 | NPC1 (0.38) | DAPK3PRKACAMAPK9CSNK1A1ROCK1 | |
| SCHEMBL15558971 | 0.73 | MAPK1 (0.42) | DAPK3JAK2PRKD3MAP4K4ABL1 | |
| SCHEMBL19697709 | 0.73 | ALDH1A1 (0.45) | DAPK3JAK2PRKD3MAP4K4ABL1 | |
| SCHEMBL20743802 | 0.71 | IDO1 (0.40) | ALDH1A1KDM4EMAPTHPGDHSD17B10 | |
| SCHEMBL2869554 | 0.69 | KMT2A (0.33) | DAPK3JAK2PRKD3MAP4K4ABL1 | |
| SCHEMBL16945271 | 0.69 | MAPT (0.43) | ALDH1A1KDM4ESMN1; SMN2RAB9AMAPT | |
| SCHEMBL17810292 | 0.67 | SMN1; SMN2 (0.39) | DAPK3JAK2PRKD3MAP4K4ABL1 | |
| SCHEMBL23585406 | 0.65 | ALDH1A1 (0.41) | ALDH1A1KDM4ESMN1; SMN2RAB9AMAPT | |
| SCHEMBL11328461 | 0.64 | MAPT (0.39) | ALDH1A1KDM4ESMN1; SMN2RAB9AMAPT | |
| SCHEMBL19695450 | 0.63 | MAPK1 (0.47) | DAPK3JAK2PRKD3MAP4K4ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | DAPK3 2014/4885JAK2 1103/4885PRKD3 1114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.